Abzena

  • Abzena's Biologics cGMP Manufacturing Facility
About Abzena

Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From early-stage discovery through commercial manufacturing, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments to patients in need. The company has research, development, and cGMP facilities across locations in San Diego, CA, USA, Bristol, PA, USA and Cambridge, UK. Learn more at abzena.com.

Certifications
  • US
  • 2018
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Pharmaceutical company
Primary activities
Contract Research Organisation
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Abzena (3)

  • Bioconjugation & Complex Chemistry Development and Manufacturing

    Product Bioconjugation & Complex Chemistry Development and Manufacturing

    Specialized ADC, bioconjugate and linker payload services. Moving medicines created with ADCs, bioconjugates and linker payloads forward is where we’re at our best. And it’s made Abzena a leader in delivering on their promise. Building on the unmatched expertise of our scientists, the IP we’ve generated,...
  • Biologics process development and analytical method development

    Product Biologics process development and analytical method development

    Developing an efficient, scalable, validated, and cost-effective manufacturing process is essential for success in today’s competitive biologics markets. Whether you need assistance developing a new process, are improving existing processes, or are preparing to manufacture your product, you will benefit f...
  • Lead Discovery and design

    Product Lead Discovery and design

    Abzena’s antibody discovery team collaborates with you to build the foundations of a successful program and de-risk your development path. We deliver expert assessments of target molecules, immunization strategies and antibody screening cascades that inform your selection of the best candidates for develo...

Abzena Resources (2)

  • News CPHI Podcast Series: The power of proteins in antibody drug development

    In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. 
  • Brochure Abzena's Best-in-Class Biologics & Bioconjugate CDMO+CRO Services

    At Abzena, our focus is on providing a de-risked and streamlined development pathway for our customers. As the leading CDMO + CRO for complex biologics and bioconjugates and ADCs, we support customers with fully integrated programs or individual tailored services that span from early-stage research and discovery through commercial launch to ensure that your program progresses smoothly through the critical path and rapidly advances to its next milestone.